China Medicine Corporation (CHME)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2009 | 9.03 Million USD | 423.6% |
| 2008 | -2.79 Million USD | 51.6% |
| 2007 | -5.76 Million USD | -1452.65% |
| 2006 | -371.48 Thousand USD | -1322.05% |
| 2005 | 30.39 Thousand USD | 112.48% |
| 2004 | -243.52 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2010 Q1 | 326.46 Thousand USD | -96.39% |
| 2010 Q2 | -4.13 Million USD | -1365.4% |
| 2010 Q3 | -4.65 Million USD | -12.63% |
| 2009 Q3 | 691.41 Thousand USD | 138.11% |
| 2009 Q4 | 9.03 Million USD | 1206.64% |
| 2009 Q2 | -1.81 Million USD | -2.44% |
| 2009 FY | 9.03 Million USD | 423.6% |
| 2009 Q1 | -1.77 Million USD | 36.57% |
| 2008 FY | -2.79 Million USD | 51.6% |
| 2008 Q4 | -2.79 Million USD | -3.02% |
| 2008 Q3 | -2.71 Million USD | 2.21% |
| 2008 Q2 | -2.77 Million USD | 46.47% |
| 2008 Q1 | -5.17 Million USD | 10.24% |
| 2007 Q1 | -2.31 Million USD | -522.36% |
| 2007 Q4 | -5.76 Million USD | -39.72% |
| 2007 FY | -5.76 Million USD | -1452.65% |
| 2007 Q3 | -4.12 Million USD | -52.74% |
| 2007 Q2 | -2.7 Million USD | -16.9% |
| 2006 Q2 | -508.29 Thousand USD | 71.09% |
| 2006 FY | -371.48 Thousand USD | -1322.05% |
| 2006 Q4 | -371.48 Thousand USD | 42.14% |
| 2006 Q1 | -1.75 Million USD | -5884.19% |
| 2006 Q3 | -642.02 Thousand USD | -26.31% |
| 2005 FY | 30.39 Thousand USD | 112.48% |
| 2005 Q4 | 30.39 Thousand USD | 0.0% |
| 2004 FY | -243.52 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| DH Enchantment Inc. | 409.44 Thousand USD | -2106.497% |
| Exlites Holdings International, Inc. | - USD | -Infinity% |
| Itonis, Inc. | 909.99 Thousand USD | -892.792% |
| One Step Vending Corp. | 247.1 Thousand USD | -3556.05% |
| MediPal Holdings Corporation | -1.49 Billion USD | 100.603% |
| PD-Rx Pharmaceuticals, Inc. | -6.83 Million USD | 232.207% |
| Pharmagen, Inc. | 4362.26 USD | -207003.451% |
| Suzuken Co., Ltd. | -1.17 Billion USD | 100.768% |